Pictet Asset Management (UK)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
$2.12M Buy
106,323
+4,147
+4% +$82.8K ﹤0.01% 992
2021
Q1
$2.36M Sell
102,176
-17,500
-15% -$404K ﹤0.01% 951
2020
Q4
$2.96M Sell
119,676
-3,600
-3% -$88.9K ﹤0.01% 910
2020
Q3
$5.11M Buy
123,276
+23,459
+24% +$973K 0.01% 713
2020
Q2
$4.78M Sell
99,817
-849
-0.8% -$40.7K 0.01% 699
2020
Q1
$6.34M Buy
100,666
+15,300
+18% +$963K 0.01% 574
2019
Q4
$10.6M Buy
85,366
+44,345
+108% +$5.5M 0.02% 552
2019
Q3
$2.72M Buy
41,021
+4,500
+12% +$299K 0.01% 801
2019
Q2
$2.91M Sell
36,521
-66,879
-65% -$5.32M 0.01% 793
2019
Q1
$11.6M Buy
103,400
+34,300
+50% +$3.84M 0.03% 490
2018
Q4
$6.97K Buy
69,100
+19,400
+39% +$1.96K 0.02% 570
2018
Q3
$6.28M Sell
49,700
-6,100
-11% -$771K 0.01% 662
2018
Q2
$4.68M Buy
55,800
+4,200
+8% +$352K 0.01% 679
2018
Q1
$3.17M Buy
+51,600
New +$3.17M 0.01% 742
2017
Q4
Sell
-9,909
Closed -$575K 914
2017
Q3
$575K Sell
9,909
-8,100
-45% -$470K ﹤0.01% 848
2017
Q2
$2.02M Sell
18,009
-88,654
-83% -$9.92M 0.01% 786
2017
Q1
$12.1M Buy
106,663
+10,031
+10% +$1.13M 0.04% 445
2016
Q4
$10.5M Buy
96,632
+7,721
+9% +$839K 0.04% 439
2016
Q3
$14.6M Sell
88,911
-47,026
-35% -$7.74M 0.06% 372
2016
Q2
$20.2M Buy
135,937
+110,487
+434% +$16.4M 0.08% 290
2016
Q1
$2.84M Sell
25,450
-27,444
-52% -$3.06M 0.01% 642
2015
Q4
$7.9M Buy
52,894
+4,193
+9% +$626K 0.03% 457
2015
Q3
$8.08M Buy
48,701
+4,678
+11% +$776K 0.04% 442
2015
Q2
$11.6M Buy
44,023
+17,624
+67% +$4.65M 0.05% 396
2015
Q1
$6.67M Sell
26,399
-9,555
-27% -$2.42M 0.03% 523
2014
Q4
$5.61M Buy
35,954
+30,254
+531% +$4.72M 0.03% 546
2014
Q3
$1.35M Buy
5,700
+700
+14% +$166K 0.01% 774
2014
Q2
$1.18M Buy
5,000
+200
+4% +$47.3K 0.01% 775
2014
Q1
$1.58M Buy
+4,800
New +$1.58M 0.01% 757